![]() |
|
|
Forward to a colleague |
||
Access Full Stories Agilent and BioTrove are collaborating to deliver ultra high-throughput sample preparation and mass spectrometry (MS) systems to speed the analysis of in vitro assays used in drug development... Read Guarding against the misuse of synthetic genomics A new report has outlined a series of recommendations for government policymakers to help mitigate the potential risks of the burgeoning synthetic genomics area... Read Foot-tapping boosts laboratory efficiency A new foot-controlled PC mouse aims to increase researchers' efficiency by removing the need for repetitive glove removal and hand washing before using laboratory computers... Read Fingerprinting the structure of pharmaceuticals A new solid-state proton NMR (nuclear magnetic resonance) technique has been developed that can quickly determine polymorphism of active pharmaceuticals within tablet formulations... Read Product news in brief - week 42 LabTechnologist.com brings you its periodic update of recent product releases, with additions from Activotec, Applied Biosystems / MDS Sciex, FEI, Invitrogen, Mettler Toledo and Torrey Pines... Read |
||||||||||||||||||
All News Headlines for: October | September | August |
||||||||||||||||||
Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here | ||||||||||||||||||
|
Related Industry News Pfizer abandons ship as Exubera sinks Pfizer revealed today that it is abandoning its once-touted blockbuster Exubera, ending months of speculation as to whether the fledging world-first inhalable insulin would sink or swim in the fierce waters of... Read BioXell says 'ciao' to enlarged prostates As men grow older, the majority of them will suffer from the symptoms of an enlarged prostate. However, help could be on the horizon from BioXell's new drug that treats both the symptoms and, crucially, the cause... Read Novartis suffers from generics, cuts jobs Novartis has turned in its results for the first nine months of the year, with income gnawed at by generic competition and product suspensions, but still claiming record earnings helped along by divestment gains... Read Online drug discovery services database to be launched A US start-up firm is gearing up to launch an online database where researchers can access a variety of drug discovery service providers across the globe... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||